Glaxo Smith Kline
Glaxo Smith Kline operates in various business sectors.
Market Cap & Net Worth: Glaxo Smith Kline (BIOC)
Glaxo Smith Kline (EGX:BIOC) has a market capitalization of $10.91K (EGP551.43K) as of March 18, 2026. Listed on the EGX stock exchange, this Egypt-based company holds position #44752 globally and #45 in its home market, demonstrating a 0.45% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Glaxo Smith Kline's stock price EGP60.77 by its total outstanding shares 9074 (9.07K).
Glaxo Smith Kline Market Cap History: 2015 to 2026
Glaxo Smith Kline's market capitalization history from 2015 to 2026. Data shows growth from $1.40K to $10.91K (21.85% CAGR).
Glaxo Smith Kline Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Glaxo Smith Kline's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of BIOC by Market Capitalization
Companies near Glaxo Smith Kline in the global market cap rankings as of March 18, 2026.
Key companies related to Glaxo Smith Kline by market ranking:
- BORYSZEW (MU:BOW): Ranked #44743 globally with a market cap of $11.48K USD ( €11.19K EUR).
- FIBRA Storage (MX:STORAGE18): Ranked #44744 globally with a market cap of $11.46K USD ( MX$236.16K MXN).
- POSTNL (HM:TNTC): Ranked #44753 globally with a market cap of $11.40K USD ( €11.11K EUR).
- SCHUMAG (SCM.SG) (STU:SCM): Ranked #44754 globally with a market cap of $11.40K USD ( €11.11K EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #44743 | BORYSZEW | MU:BOW | $11.48K | €1.23 |
| #44744 | FIBRA Storage | MX:STORAGE18 | $11.46K | MX$25.60 |
| #44753 | POSTNL | HM:TNTC | $11.40K | €1.13 |
| #44754 | SCHUMAG (SCM.SG) | STU:SCM | $11.40K | €1.21 |
Glaxo Smith Kline Historical Marketcap From 2015 to 2026
Between 2015 and today, Glaxo Smith Kline's market cap moved from $1.40K to $ 10.91K, with a yearly change of 21.85%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | EGP10.91K | -4.52% |
| 2025 | EGP11.42K | +76.81% |
| 2024 | EGP6.46K | +1.27% |
| 2023 | EGP6.38K | -6.84% |
| 2022 | EGP6.85K | +23.58% |
| 2021 | EGP5.54K | +82.08% |
| 2020 | EGP3.04K | -14.17% |
| 2019 | EGP3.55K | 0.00% |
| 2018 | EGP3.55K | +45.48% |
| 2017 | EGP2.44K | +87.35% |
| 2016 | EGP1.30K | -6.87% |
| 2015 | EGP1.40K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Glaxo Smith Kline was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $10.91K USD |
| MoneyControl | $10.91K USD |
| MarketWatch | $10.91K USD |
| marketcap.company | $10.91K USD |
| Reuters | $10.91K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.